medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2020, Number 3

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2020; 19 (3)

Perioperative factors, immunity and cancer recurrence

Cárdenas TYY, Redondo GZ, Segura LN

Language: Spanish
References: 53
Page: 1-19
PDF size: 460.73 Kb.


ABSTRACT

Introduction: The quality criteria in radical oncological surgery are based on complete tumor removal, with free margins, without residual macroscopic disease, with adequate lymphadenectomy and minimal possible tumor manipulation. Despite achieving these objectives, non-visible residual disease or micrometastasis may remain, likely to grow and spread depending on tumor capacity and the host's defenses.
Objectives: To evaluate the influence of perioperative factors on the immunity of cancer patients operated on and the potential effect of anesthetic drugs on recurrence, as well as other perioperative factors that may affect long-term tumor spread.
Methods: An electronic bibliographic search was carried out of the articles published in the last ten years and that fulfilled the established objective.
Development: During the perioperative period, activation of the response to surgical stress triggers a series of complex neuroendocrine, humoral and immune reactions. Surgery, with unquestionable curative potential, is related to a state of immunosuppression due to activation of the hypothalamic-pituitary-adrenal axis and inflammation. On the other hand, anesthesia produces biomolecular changes that affect cellular immunity and the number of natural killers, which can influence cancer recurrence in the long term.
Conclusions: To reduce surgical and psychological stress, to control surgical pain, to maintain normothermia, and a judicious blood transfusion, in addition to an anesthetic technique with reduced opiates usage, can be beneficial to protect the body's antimetastatic immune response and can have a beneficial effect on oncological disease.


REFERENCES

  1. Coffey JC, Wang JH, Smith MJF, Bouchier-Hayes D, Cotter TG, Redmond HP. Excisional Surgery for cancer cure: therapy at a cost. Lancet Oncol. 2003;232:58-65. DOI: https://doi.org/10.1016/S1470-2045(03)01282-8

  2. Ryungsa K. Effects of Surgery and anesthetics choice on immunossuppression and cancer recurrence. J Transl Med. 2018;16:8. DOI: https://org/10.1686/S12967-018-1389-7

  3. Mille Loera JE, Cuéllar Guzmán LF, Alvarado Pérez J, García Velazco O, Fabela Barragán A. Consideraciones anestésicas en el paciente con cancer. Rev. Mex. Anest. 2017[acceso: 25/05/2019];40(1):132-34. Disponible en: https://www.medigraphic.com/pdfs/rma/cma-2017/cmas171al.pdf

  4. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. B.J.A. 2000;105(2):106-15: DOI: https://doi.org/10.1093/bja/aeq164

  5. Zhu J, Zhang XR, Yang H. Effects of combined epidural anaesthesia and general anaesthesia on intraoperative hemodynamic, and responses proliferative cellular immunity and prognosis in patients with gall blade cancer: arandomized controlled trial. Medicine Baltimore. 2017;96:6137. DOI: https://doi.org/10.1097/MD.0000000000006137

  6. Cottrell JE. View from the head of the table: against putting people to sleep. Surg Rounds. 1989;12:81-88.

  7. Bartal I, Melamed R, Greenfeld K, Atzil S, Glasner A. Immune perturbations in patients along the perioperative period: alterations in cell surface markers and leukocyte subtypes before and after surgery. BrainBehavImmun. 2010;24:376-86. DOI: https://doi.org/10.1016/j.bbi.2010.03.002

  8. Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol. 2015;12:213-26. DOI: https://doi.org/10.1038/nrclinonc.2014.224

  9. Bonilla Castillo, Pérez Herrero MA, Abad Torren A. Efectos de la anestesia en la cirugía Oncológica. Rev. Electrónica del Grupo de Anestesia total Intravenosa GTIV On Line: GATIV. 2017. DOI: https://doi.org/10.1002/ ijc.26448/full

  10. Kim R. Anesthetics technique and cancer recurrence in oncologic surgery: unraveling the puzzle. Cancer metastasis Rev. 2017;6:159-77. DOI: https://doi.org/10.1007/s10555-016-9647-8

  11. Steve N. ¿Influye la Anestesia en los resultados de la Cirugía Oncológica? Rev. Soc. Esp. Dolor. 2014;21(3):162-74. DOI: https://dx.doi.org/10.4321/S1134-80462014000300007

  12. Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperatory period to improve long-term cancer outcome. Nat Rev Clin Oncol. 2015;12(4):213-26. DOI: https://doi.org/10.1038/nrclinonc.2014.2014.224

  13. Wenjin Y, Cai J, Zabkiewicz C, Zhang H, Rugi F, Wen GJ. The effects of anesthetics on Recurrence and metastasis cancer and clinical implications. World J Oncol. 2017;8(3):63-70. DOI: https://doi.org/10.14740/wjon1031e

  14. Hogan BV, Peter MB, Shenoy HG, Horgan K, Hughes TA. Surgery inducedimmunos suppression. The Surgeon. 2011;9(1):38-43: DOI: https://doi.org/10.1016/j.surge.2010.07.011

  15. Cortinas SM, Mallo GP, Martinez GC, Prado MA. ¿Pueden las diferentes técnicas Anestésiscas empleadas en cirugía oncológica de mama disminuir el riesgo de recidiva tumoral? Progresos de Obstetricia y Ginecología. 2011;54(2):91-95. DOI: https://doi.org/10.1016/j. pog.2010.11.012

  16. Gómez ST, Arroyo FF, Gómez SL. Impacto del manejo perioperatorio en el pronóstico oncológico del cáncer de mama no metastásico. Un paradigma del futuro. Rev. de Senol. y Patología Mamaria. 2018;31(2):67-71. DOI: https://doi.org/10.1016/j.senol.2018.03.005

  17. Esteve N, Valdivia J, Ferrer A, Ribera H, Garrido P. ¿Influyen las técnicas anestésicas en los resultados postoperatorios? Parte II Rev Esp Anestesiol Reanim. 2013;60(2):93-102. DOI: https://dx.doi.org/10.1016/j.redar.2012.09.002

  18. Mejía GL. Fisiopatología del shock Hemorrágico. Anestesia en el paciente con trauma. Rev. Mex de Anestesiología. 2014[acceso: 07/07/2017];37(1):570-76. Disponible en: http://www.medigraphic.com./rma

  19. Grantt CL. Red Blood cells for cancer petients. The Lancet. 1981;318(8242):363. Disponible en: DOI: https://doi.org/10.1016/S0140-6736(81)90673-5

  20. Blumberg N, Heal JM. Transfusion and host defenses against cancer recurrence and infection. Transfusion. 1989;29(3):236-45. DOI: https://doi.org/10.1046/j.1537-2995.1989.29389162731.x

  21. Muñoz M, Llau Pitarch JV, Lael Noval SR, García Erce JA, Culebras Fernández JM. Transfusión sanguínea perioperatoria en el paciente neoplásico, Alteraciones inmunológicas y consecuencias clínicas. CirEsp. 2002[acceso: 25/05/2019];72(3):160-8. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0009739X02720320

  22. Neeman E, Ben-Eliyahu S. Surgery and stress promote cancer metastasis: New outlooks on perioperative mediating mechanisms and immune involvement. Brain BehavImmun. 2013;30:32-40. DOI: https://dx.doi.org/10.1016/j.bbi.2012.03.006

  23. Byrne K, Levins KJ, Buggy DJ. Can anesthetic-analgesic technique during primary cancer surgery affect recurrence or metastasis? Can J Anesth. 2016;63(2)184-92. DOI: https://10.1007/s12530-015-0523-8

  24. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumour metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanism and prophylactic measures. Anesth Analg. 2003;97:1331-9. DOI: https://10.1213/01. ane.0000082995.44040.0

  25. Heaney A, Buggy DJ; ¿Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? B.J.A. 2012;109(1):17-28. DOI: https://doi.org/10.1093/bja/aes421

  26. Coloma JR, Monteagudo Y. Sobrevida y recurrencia a largo plazo de pacientes sometidos a cirugía oncológica asociada al tipo de anestesia. Contacto Científico. 2016[acceso: 07/07/2017];6(5):270-73. Disponible en: http://contactocientífico.alemana.cl/ojs/index.php/cc/article/view/373>

  27. García Miguel FJ, Peyró R, Mirón RMF. Valoración anestésica pre-operatoria y preparación del paciente quirúrgico. Rev Esp Anestesiol Reanim. 2013[acceso: 25/05/2019];60:11-26. Disponible en: https://medes.com/publication/82550

  28. Cuéllar GN. Impacto de la técnica anestésica en la recurrencia del cáncer. Rev. Mex. Anestesiología. 2014[acceso: 07/07/2017];37(1):296-98. Disponible en: https://www.medigraphic.com/pdfs/rma/cma-2014/cmas141bz.pdf

  29. Zilbestein G, Levy R, Levy R, Rachinsky M, Fisher A, Greemberg L, et al. Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth Analg. 2002,95:531-36. DOI: https://doi.org/10.1013/00000539-200209000-00005

  30. Muthukumaraswuamy SD, Alexander D. Shaw LE. Jackson JH, Moran R, Neeraj S. Evidence that sub-anesthetic doses of ketamine cause sustained disruptions of NMDA and AMP-mediated frontoparietal connectivity in humans. J. Neurosci. 2015;35:11694-706. DOI: https:// doi.org/10.1523/ JNEUROSCI-0903-15-2015

  31. Meier A, Nizet V. Impact of anestehesia on human neutrophil function. Anesth Anal. 2019;128:569-74. DOI: https:// doi.org/10.1213/ ANE.0000000000003997

  32. Clemenceau P. Anestesia y recurrencia. Rev. Mex Anestesiol. 2015[acceso: 07/07/2017];38(1):318-19. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=58895

  33. Bolan JW, Williams McK, Ahmedzai SH, Pockley AG. Effects of opioids on immmunologic parameters that are relevant to antiumour immune potential in patients with cancer, a sistematic literature review. Br J. Cancer. 2014;111(15): 886-73. DOI: https://doi.org/10.1038/bjc. 2014. 384

  34. P. Forget, Collet V, Lavand'homme P, De Kock M. Does analagesia and anesthesia condition influence immunity after surgery? Effects of fentanyl, Ketamine, and clonidine on natural killer activity at different ages. Eur Jour of Anest. 2009;27(3):233-40. DOI: https://doi.org/10.1097/EJA. 0b0 13e 32832d540e

  35. Gaspani L, Branchi M, Limiroli E, E Panerai A. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and matastatic colonization in rats. J Neuroimmunol. 2002;129(1-2):18-24. DOI: https://doi:org/10-1016/S0165-5728(02)00165-0

  36. Ash SA, Buggy DJ. Does regional anaesthesia and analgesia or opioid analgesia, influence recurrence after primary cancer surgery? An update of available evidence. Best Pract. Res. Clin. Anesthesiolol. 2013;27:441-56. DOI: https://doi:org/10-1016/j.bpa.2013.10.005

  37. Dubowitz JA, Sloan EK, Reidel BJ. Implicating anesthesia and the perioperative period in cancer recurrence and metastasis. Clin Exp Metastasis. 2018;35(4):347-58. DOI: https://doi:org/10.1007/s10585-0179862x

  38. Ramos Costoya J. Efectividad del bloqueo paravertebral eco guiado para cirugías de sarcomas de la pared toráxica y retroperitoneo. AVA. Rev. Mex. de Anestesiol. 2011[acceso: 07/07/2017];38(1):329-32. Disponible en: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiF-oa9_b7rAhXut1kKHUcuCyIQFjAAegQIBBAB&url=https%3A%2F%2Fwww.medigraphic.com%2Fpdfs%2Frma%2Fcma-2015%2Fcmas151cj.pdf&usg=AOvVaw2Rf958IQXYDtGsAOPgQON

  39. Floppa A, Kiefer RT, Wolfgang A Krueger, Klaus E Unerti. Local anesthesia time- dependently inhibit staphylococcus aureus phagocytosis, oxidative burst and CD 11b expression by human neutrophils. Reg. Anesth Pain Med. 2008;33:297-303. DOI: https://doi:org/10.1016/j.rapm.2007.05.012

  40. Trautmann A, Stoevesandtn J. Differential diagnosis of late-type reactions to injected local anesthetics: Inflammation at the injection site is the only indicator of allergic Hypersensitivity. Contac Dermatitis. 2019;80(2):118-24. DOI: https://doi:org/10.1111/cod.13130

  41. Marino F, Catteneo S, Cosentino. Diazepam stimulates migration and phagocytosis of human neutrophils: possible contribution of peripheral-type benzodiazepine receptors and intracelular calcium. Pharmacology. 2001;63:42-9. DOI: https://doi:org/10.1159/000056111

  42. Alka Kewatramani, Partani S, Sharma NP, Sharma V. Comparision of labetalol versus dexmedetomidina to assess the hemodynamic responses to laryngoscopy and intubation during induction of general anesthesia a prospective, randomized, controlled study. Indian Journal of Clinical Anesthesia. 2016;3(4):512-17. DOI: https://doi:org/10.18231/2394-4994.2016.0005

  43. Herrera García AM, Domínguez Luis MJ, Arce Franco M, Armas González E, Álvarez de La Rosa D, Machado JD, et al. Prevention of neutrophil extravasation by alpha 2 adrenoreceptor-mediated endothelial stabilization. J Immunol. 2014;193(6):3023-25. DOI: https://doi.org/10.4049/jimmunol.1400255

  44. Lennon FE, Mirzapoiazova T, Mambetsariev B, Poroyko VA, Salgia R. The Mu opioid receptor promotes opioid and growth factor-induced proliferation migration and Epithelial Mesenchimal Transition (EMT) in human lung cancer. PLoS One. 2014;9(3):91577. DOI: https://doi.org/10.1371/journal.pone.0091577

  45. Wang Y, Xuefeng X, Hong L, Fuhai J. Effects of Dexmedetomidine on patients undergoing radical gastrectomy. JSR. 2014;94(1):147-53. DOI: https://doi.org/10.1016/j.jss.2014.10.008

  46. P Cata J, Singh V, M Lee B, Villarreal J, R Mehran J, Yu J, et al. Intraoperative use of Dexmedetomidine is associated with decreased overall survival after lung cancer surgery. J Anesthesiol Clin Pharmacol. 2017;33(3):317-23. DOI: https://doi.org/10.4103/joacp.JOACP_299_16

  47. Rosenne E, Sorski L, Shaashua L, Neeman E, Matzner P, Levi B, et al. In vivo suppression of NK cell, cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins. Brain Behav Immun. 2014;37:207-19. DOI: https://doi.org/10.1016/j.bbi.2013.12.007

  48. Bruzzone A, Piñero CP, Castillo LF, Sarappa MG, Rojas P, Lanari C, et al. Alpha 2 -adrenoreceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol. 2008;155:494-504. DOI: https://doi.org/10.1038/bjp.2008.278

  49. Mercedes J Szpunar, Kathleen A Burke, Ryan P Dawes, Edward B Brown, Kelley S Madden. The antidepressant disipramine and alpha2-adrenergic receptor activation promote breast tumor progression association with altered collagen structure. Cancer Prev. Res (Phila) 2013;6:1262-72. DOI: https://doi.org/10.1158/1940-6207.CAPR-13-0079

  50. H Lavon P, Matzner A, Benbenishty L, Sorski E, Rossene R. Haldar. Dexmedetomidina promotes metastasis in rodent models of breast, lung and colon cancer. Br J Anesth. 2018;120(1):188-96. DOI: https://doi.org/10.1016/j.bja.2017.11.004

  51. Freeman J, Buggy DJ. Modelling the effects of perioperative interventions on cancer outcome: lesson of Dexmedetomidina. Brith J of Anesthesia. 2018;120(1):15-17. DOI: https://doi.org/10.1016/j.bja.2017.11.001

  52. Rekha Das, Rajat Kumar Das, Sushrita Sahoo, Suchismita Nanda. Rol of Dexmedetomidina as an anesthetic adjuvant in breast cancer surgery as a day-care procedure. A randomized control study. Indian J Anesth. 2018;62(3):182-87. DOI: https://doi.org/10.4103/ija.IJA_752_17

  53. Marisol Zarasúa J, Gabriel Gómez Sánchez, García Morán EA. Alto Riesgo perioperatorio en el paciente oncológico sometido a cirugía no oncológica. Rev. Mex. de Anestesiol. 2016[acceso: 07/02/2017];39(1):76-78. Disponible en: https://www.medigraphic.com/pdfs/rma/cma-2016/cmas161x.pdf




2020     |     www.medigraphic.com